Correction to: Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma

Ann Surg Oncol. 2020 Dec;27(Suppl 3):965. doi: 10.1245/s10434-020-08249-4.

Authors

Amr I Al Abbas^{1

2}, Mazen Zenati¹, Caroline J Rieser¹, Ahmad Hamad^{1

3}, Jae Pil Jung^{1

4}, Amer H Zureikat¹, Herbert J Zeh 3rd^{1

2}, Melissa E Hogg^{5

6}

Affiliations

¹ University of Pittsburgh, Pittsburgh, PA, USA.
² University of Texas Southwestern, Dallas, TX, USA.
³ Ohio State University, Columbus, OH, USA.
⁴ Andong Medical Group Hospital, Andong-si, Gyeongbuk, Korea.
⁵ University of Pittsburgh, Pittsburgh, PA, USA. MHogg@Northshore.org.
⁶ Walgreens Building, Department of Surgery 2539, Northsore University HealthSystem, 2650 Ridge Road, Evanston, IL, 60201, USA. MHogg@Northshore.org.

PMID: 32034575
DOI: 10.1245/s10434-020-08249-4

Abstract

In the original article, Caroline J. Rieser's last name is spelled wrong. It is correct as reflected here.

Publication types

Published Erratum

Grants and funding

T32 CA113263/CA/NCI NIH HHS/United States